These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11332229)

  • 1. [Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany. A prospective cost of illness study].
    Rychlik R; Pfeil T; Daniel D; Pfeil B; Mast O; Thate-Waschke I; Lorenz J
    Dtsch Med Wochenschr; 2001 Mar; 126(13):353-9. PubMed ID: 11332229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany].
    Weissflog D; Matthys H; Virchow JC
    Dtsch Med Wochenschr; 2001 Jul; 126(28-29):803-8. PubMed ID: 11499261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost of asthma therapy in relation to severity. An empirical study].
    Graf von der Schulenburg JM; Greiner W; Molitor S; Kielhorn A
    Med Klin (Munich); 1996 Oct; 91(10):670-6. PubMed ID: 9019647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.
    Berger K; Ehlken B; Kugland B; Augustin M
    J Dtsch Dermatol Ges; 2005 Jul; 3(7):511-8. PubMed ID: 15967010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment cost of acute exacerbations of chronic bronchitis.
    Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
    Clin Ther; 1999 Mar; 21(3):576-91. PubMed ID: 10321424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cost of illness study of diabetes mellitus].
    von Ferber L; Köster I; Hauner H
    Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The social cost of chronic bronchitis in Mexico City: a pilot study].
    Avila-Burgos L; Gutiérrez-Zúñiga C; Hernández-Peña P; OFFtos-Burgoa C; Silva-Aycaguer L
    Salud Publica Mex; 1996; 38(2):128-38. PubMed ID: 8693351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of drug treatment in Parkinson's disease.
    Dodel RC; Eggert KM; Singer MS; Eichhorn TE; Pogarell O; Oertel WH
    Mov Disord; 1998 Mar; 13(2):249-54. PubMed ID: 9539337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost evaluation by a patient questionnaire: pilot study of a weekly cost diary].
    Becker A; Seitz R; Jacobi E; Leidl R
    Rehabilitation (Stuttg); 2001 Feb; 40(1):12-20. PubMed ID: 11253749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of venous leg ulcer by French physicians, diversity and related costs: a prospective medicoeconomic observational study].
    Lévy E; Lévy P
    J Mal Vasc; 2001 Feb; 26(1):39-44. PubMed ID: 11240528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A cost analysis of diagnostic screening for the differentiation of type-1 and type-2 diabetics aged 30 to 45. A health economics modelling calculation].
    Kilburg A; Bruchhausen Y; Thomas J; Rychlik R
    Dtsch Med Wochenschr; 1999 Dec; 124(50):1510-7. PubMed ID: 10633777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin.
    Li-McLeod J; Perfetto EM
    Manag Care Interface; 2001 Feb; 14(2):52-9. PubMed ID: 11228817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.